CN113999792B - 一种双歧杆菌增殖促进剂及其制备方法和应用 - Google Patents
一种双歧杆菌增殖促进剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN113999792B CN113999792B CN202111276939.7A CN202111276939A CN113999792B CN 113999792 B CN113999792 B CN 113999792B CN 202111276939 A CN202111276939 A CN 202111276939A CN 113999792 B CN113999792 B CN 113999792B
- Authority
- CN
- China
- Prior art keywords
- oyster extract
- gam
- bifidobacterium
- intestinal
- proliferation promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000035755 proliferation Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 241000186000 Bifidobacterium Species 0.000 title abstract description 40
- 241000237502 Ostreidae Species 0.000 claims abstract description 44
- 235000020636 oyster Nutrition 0.000 claims abstract description 44
- 239000000284 extract Substances 0.000 claims abstract description 25
- 239000001963 growth medium Substances 0.000 claims abstract description 20
- 239000002609 medium Substances 0.000 claims abstract description 16
- 239000000243 solution Substances 0.000 claims description 17
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 5
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 12
- 239000006041 probiotic Substances 0.000 abstract description 11
- 235000018291 probiotics Nutrition 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 244000005700 microbiome Species 0.000 abstract description 9
- 206010009944 Colon cancer Diseases 0.000 abstract description 8
- 206010010774 Constipation Diseases 0.000 abstract description 8
- 208000029742 colonic neoplasm Diseases 0.000 abstract description 7
- 238000012258 culturing Methods 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000028774 intestinal disease Diseases 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 4
- 235000013402 health food Nutrition 0.000 abstract description 4
- 238000000338 in vitro Methods 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 235000013376 functional food Nutrition 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 241000548230 Crassostrea angulata Species 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 108091033760 Oncomir Proteins 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000011177 media preparation Methods 0.000 description 1
- 108091070501 miRNA Proteins 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/34—Animal material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110983526 | 2021-08-25 | ||
CN2021109835266 | 2021-08-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113999792A CN113999792A (zh) | 2022-02-01 |
CN113999792B true CN113999792B (zh) | 2023-08-22 |
Family
ID=79925635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111276939.7A Active CN113999792B (zh) | 2021-08-25 | 2021-10-29 | 一种双歧杆菌增殖促进剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113999792B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009125055A (ja) * | 2007-11-28 | 2009-06-11 | Kagoshima Univ | ビフィズス菌および乳酸菌の増殖促進剤 |
JP2014143986A (ja) * | 2013-01-30 | 2014-08-14 | Ito En Ltd | 乳酸菌含有飲食品及びその製造方法 |
JP2021065133A (ja) * | 2019-10-21 | 2021-04-30 | 日清食品ホールディングス株式会社 | ビフィズス菌増殖用組成物 |
CN112980734A (zh) * | 2021-03-24 | 2021-06-18 | 江南大学 | 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2842560A4 (en) * | 2012-04-23 | 2015-12-02 | Univ Kyoto | COMPOSITION FOR PROMOTING BIFIDOBACTERIUM GROWTH |
-
2021
- 2021-10-29 CN CN202111276939.7A patent/CN113999792B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009125055A (ja) * | 2007-11-28 | 2009-06-11 | Kagoshima Univ | ビフィズス菌および乳酸菌の増殖促進剤 |
JP2014143986A (ja) * | 2013-01-30 | 2014-08-14 | Ito En Ltd | 乳酸菌含有飲食品及びその製造方法 |
JP2021065133A (ja) * | 2019-10-21 | 2021-04-30 | 日清食品ホールディングス株式会社 | ビフィズス菌増殖用組成物 |
CN112980734A (zh) * | 2021-03-24 | 2021-06-18 | 江南大学 | 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用 |
Non-Patent Citations (1)
Title |
---|
海洋生物活性物质 主要功能特性的研究进展;蔡路昀等;食品工业科技;第38卷(第7期);376-380,384 * |
Also Published As
Publication number | Publication date |
---|---|
CN113999792A (zh) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9427452B2 (en) | Method for preparing fermentation broth of fruits and vegetables | |
JP5498698B2 (ja) | シロキクラゲ雑多糖またはその抽出物の新用途 | |
Skenderidis et al. | The effect of encapsulated powder of goji berry (Lycium barbarum) on growth and survival of probiotic bacteria | |
CN103655637A (zh) | 胚芽乳酸杆菌cmu995菌株的新用途 | |
CN104770575B (zh) | 一种黄芪微生态制剂及其制备方法和应用 | |
CN110157647A (zh) | 一种能够缓解焦虑、改善睡眠的短乳杆菌及其用途 | |
CN102899276B (zh) | 一株具有降胆固醇能力的嗜热链球菌及其应用 | |
CN113925854B (zh) | 绿原酸在制备Anaerostipes生长促进剂中的应用 | |
CN114574406B (zh) | 鼠李糖乳杆菌菌株wka55及其在制备防治酒精性肝损伤制品方面的用途与产品 | |
CN113736715B (zh) | 一株嗜热链球菌s131及其在免疫调节领域中的应用 | |
CN113908166B (zh) | N-乙酰神经氨酸在制备用于促进Roseburia增殖的促进剂中的用途 | |
CN113662936A (zh) | Egcg在制备调节肠道菌群药物中的应用 | |
CN113999792B (zh) | 一种双歧杆菌增殖促进剂及其制备方法和应用 | |
CN115927116A (zh) | 一种具有降甘油三酯、降胆固醇、减脂的发酵乳杆菌菌株及其应用 | |
CN113975329A (zh) | 南非醉茄提取物在制备促进肠道有益菌增殖的产品中的应用 | |
CN108157978A (zh) | 一种含牛蒡多糖的调节肠道菌群的多肽组合物及应用 | |
CN113975317A (zh) | 黄连在制备促进肠道有益菌增殖的产品中的应用 | |
CN113842437A (zh) | 百部在制备抑制肠道菌群增殖的产品中的应用 | |
CN115104735A (zh) | 一种含有中药成份能提高机体免疫力的益生菌组合物 | |
CN113908183B (zh) | 积雪草总苷在制备乳杆菌增殖促进剂中的应用 | |
CN102805341B (zh) | 一种山芪参胶囊的五次发酵制备方法 | |
CN113974159B (zh) | 齿叶乳香树树脂在制备促进肠道有益菌增殖的产品中的应用 | |
CN113855716A (zh) | 红石榴在制备抑制多种肠道菌繁殖的产品中的应用 | |
CN114010626A (zh) | 柠檬酸在制备定向促进肠道有益菌增殖的产品中的应用 | |
CN113768996B (zh) | 缬草在制备促进肠道有益菌增殖的产品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240408 Address after: 430000 No. 04, floor 4, building B10, phase I, Wuhan hi tech medical device Park, No. 818, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province Patentee after: MAINTAIN BIOMEDICAL (WUHAN) Co.,Ltd. Country or region after: China Address before: 430000 No. B11, Gaoke medical instrument Park, No. 818, Gaoxin Avenue, Donghu Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan Yiding Tianyang Biotechnology Co.,Ltd. Country or region before: China |